MedTrace Logo

COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A

NCT05531019 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2023-02-28

No results posted yet for this study

Summary

The aim of this study is to assess the efficacy and efficiency of a nutraceutical from sea urchin eggs with Echinochrome A in the inflammation of tissues in subjects with long Corona Virus (COVID) syndome

Conditions

Interventions

DIETARY_SUPPLEMENT

Echinochrome A

Dietary Supplement with Echinochroma A Simple randomized design, in this arm patients will take 6ml of a 0.025% Echinochroma A solution twice a day for 90 days. 3 mg of Echinochroma A will be consumed per day.

OTHER

Control

Simple randomized design, in this arm patients will take 6ml of an fructose aqueous solution twice a day for 90 days with the same flavor as the treatment

Sponsors & Collaborators

  • Universidad Nacional de la Patagonia San Juan Bosco

    collaborator UNKNOWN

  • Ministerio de Ciencia, Tecnologia e Innovación, Argentina

    collaborator UNKNOWN

  • Hospital de Infecciosas Francisco Javier Muniz

    collaborator OTHER_GOV

  • Fernando Saldarini

    lead OTHER

Principal Investigators

  • Tamara Rubilar, PhD · Universidad Nacional de la Patagonia San Juan Bosco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-22
Primary Completion
2022-12-08
Completion
2022-12-18

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05531019 on ClinicalTrials.gov